Category: Press Release

Posted on

RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy

Industry Veterans Join Team to Support the Development of Novel Cyclic Aspiration System for Ischemic Stroke

MIAMI, June 23, 2021 (GLOBE NEWSWIRE) — RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced the closing of a $15 million Series A financing. The financing was led by Santé Ventures who was joined by Epidarex Capital, Hatteras Venture Partners, Broadview Ventures, and Syntheon. RapidPulse plans to use the proceeds to advance its RapidPulse™ Cyclic Aspiration System through expanded clinical evaluation and build out its platform of proprietary catheters.

The RapidPulse™ system was developed by Syntheon, a medical device incubator focused on developing next generation medical devices. Their various products, commercialized by the largest and most trusted medical device companies in the world, have treated over 50 million patients globally in applications ranging from laparoscopic surgery, cardiovascular, and flexible endoscopy. Syntheon has over 200 issued patents since its inception over 20 years ago.

“We are pleased to have partnered with an outstanding investor syndicate to move our RapidPulse™ technology forward in the clinic,” said Sean McBrayer, CEO of Syntheon who will also serve as initial CEO of RapidPulse. “Stroke is the second leading cause of death and the third leading cause of disability worldwide, and minutes matter in improving these outcomes. This investment will help us expand our clinical results and move towards regulatory approval in the United States.”

Joining the team are industry veterans Heather Harries and Cynthia Yang. Heather most recently served as General Manager for Terumo’s aortic business and will lead product development and operations for RapidPulse. Cynthia will lead clinical development for the company, after most recently working in the neurovascular division of Medtronic.

Dennis McWilliams, partner at Santé Ventures, added, “Heather and Cynthia bring exceptional domain expertise to the team at RapidPulse, and will complement the significant engineering development experience at Syntheon. RapidPulse is a disruptive platform opportunity in neurovascular, and has the potential to significantly improve patient outcomes for ischemic stroke patients.”

ABOUT RAPIDPULSE

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinout of Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry. Visit www.rapidpulsemed.com for more information.

ABOUT SANTÉ VENTURES

Santé Ventures is a life sciences investment firm that invests in early-stage companies in medical device, biotechnology, and digitally enabled health services. We partner with entrepreneurs to build impactful companies, including Claret Medical (now part of Boston Scientific), TVA Medical (Becton Dickinson), Millipede Medical (Boston Scientific), and Molecular Templates (NASDAQ: MTEM). Founded in 2006, Santé has just under $1 billion in assets under management, and has offices in Austin, TX and Boston, MA. For more information, please visit sante.com.

ABOUT EPIDAREX CAPITAL

Epidarex Capital is a transatlantic venture capital firm that builds exceptional life science companies in emerging hubs in the US and UK. Epidarex’s experienced team of early-stage investors partner with entrepreneurs and leading research institutions to transform world-class science into highly innovative products addressing major unmet needs in global healthcare. For more information, please visit www.epidarex.com

ABOUT HATTERAS VENTURE PARTNERS

Founded in 2000 and based in Durham, NC, Hatteras Venture Partners is a venture capital firm with a focus on seed and early stage healthcare investing. Through six funds and over $600 million under management, the firm has invested in breakthrough science and entrepreneurial grit in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine. To learn more, please visit www.hatterasvp.com.

ABOUT BROADVIEW VENTURES

Founded in 2008, Broadview Ventures is a mission-driven investment organization. Broadview’s primary goal is to improve human health in the areas of cardiovascular disease and stroke through investments in early stage companies developing innovative therapeutics, devices, and diagnostics. For more information about Broadview Ventures, visit broadviewventures.org.

MEDIA CONTACT:

Sean McBrayer, info@rapidpulsemed.com, 305-266-3388

Posted on

Conformis, Inc. Announces Exclusive Distribution Agreement in China

New Agreement expands Conformis’ global reach and brings patient-specific knee replacement systems to the largest market in the Asia-Pacific region

BILLERICA, Mass., June 23, 2021 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) today announced the execution of an agreement to enter the Asia-Pacific market through an exclusive distribution relationship with XR Medical Group (Hong Kong) Limited (XR Medical).

Under the distribution agreement, XR Medical will have exclusive rights for the sale, marketing, and distribution of Conformis’ patient-specific iTotal® CR & PS total knee replacement systems, iTotal® CR & PS patella devices, and iUni® and iDuo® partial knee replacement systems. Other products, such as Conformis’ recently approved Identity Imprint™ knee system and its hip portfolio of products, may be added in the future.

XR Medical’s sales team will provide sales and support exclusively to top-tier facilities in Hainan’s Boao Lecheng International Medical Tourism Pilot Zone (Pilot Zone) on behalf of Conformis. The region is a major center of medical tourism for dozens of countries.

“This distribution agreement is another example of progress as we execute our overall growth strategy. We are confident that our unique product portfolio will serve to accelerate Conformis’ international growth. And we are pleased to partner with XR Medical, which has an impressive track record of success in China,” said Mark Augusti, President and CEO of Conformis. “What is particularly attractive about XR Medical is its strong performance in the Pilot Zone. With access to patients visiting the region for treatment, this creates an opportunity to introduce a broad audience to the clinical benefits of Conformis technology. We believe that starting in the Pilot Zone positions us well and we anticipate that this relationship will serve as a model for future expansion opportunities in mainland China.”

The Pilot Zone is located on Hainan, a large island off China’s southern coast. It was established in 2019 to attract affluent Chinese citizens who might otherwise go abroad for their medical care. This region of China has developed top-level medical treatment facilities in a popular destination. Currently, medical tourists from dozens of countries, including those in Southeast Asia, are permitted to visit Hainan for a 30-day stay without visas.

The global market for knee joint reconstruction is projected at more than $9 billion. Of this total, the knee joint reconstruction market in the Asia-Pacific region is currently estimated to exceed $1.7 billion. Fortune Business Insights predicts a high growth rate for knee replacements in the region due to the combination of the increased prevalence of knee disorders, booming medical tourism, increased disposable incomes, and improved healthcare infrastructure.

About Conformis, Inc.

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit and conform to each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and standard implants, along with single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal® CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at http://ir.conformis.com.

Cautionary Statement Regarding Forward-Looking Statements

Statements in this press release about our future expectations, plans and prospects, as well as other statements containing the words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” and similar expressions, constitute forward-looking statements within the meaning of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. You should not place undue reliance on our forward-looking statements. Actual results could differ materially from the projections disclosed in the forward-looking statements we make as a result of a variety of risks and uncertainties, including risks and uncertainties described in the “Risk Factors” sections of our public filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent our views as of the date hereof. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date hereof.

Source: Conformis, Inc.

Media Contact:
Investor Relations
ir@conformis.com
(781) 374-5598
Posted on

Liquid Instruments Introduces Moku:Pro – A High Performance, Software-Defined Instrumentation Platform for Engineers and Scientists

New architecture delivers nine instruments with real-time measurement capabilities to the research lab

Moku:Pro In Lab Setting

Moku:Pro brings test and measurement into the modern age, allowing engineers and researchers to dynamically switch between instruments rather than needing multiple stand-alone devices.

CANBERRA, Australia and SAN DIEGO, June 23, 2021 (GLOBE NEWSWIRE) — Liquid Instruments, an innovator in precision software-defined instrumentation, today announced Moku:Pro, a high-performance platform for engineering and research labs.

Moku:Pro accelerates the transition from traditional fixed-function test and measurement hardware to a flexible field-programmable gate array (FPGA)-based approach by making high-quality instruments accessible in an integrated, software-upgradeable platform.

“Researchers in engineering and physics face constantly evolving requirements – with changes occurring on timescales much shorter than the lifespan of test equipment,” said Daniel Shaddock, CEO of Liquid Instruments. “Moku:Pro’s software-enabled-hardware architecture allows it to evolve as your applications evolve, something that is simply not possible with conventional test equipment.”

Moku:Pro hosts nine powerful instruments, including an oscilloscope, lock-in amplifier, PID controller, phasemeter, arbitrary waveform generator, data logger, spectrum analyzer, frequency response analyzer, and waveform generator to ensure researchers have the instrumentation they need to quickly characterize their set up and scale their experiments. The platform was designed to meet the needs of researchers in a variety of fields, from aerospace to semiconductor. Moku:Pro’s instrument suite is particularly suited to photonics applications, including spectroscopy, microscopy, metrology, gravitational wave detection, active laser stabilization, and quantum computing.

Moku:Pro

Moku:Pro accelerates the transition from traditional fixed-function test and measurement hardware to a flexible field-programmable gate array (FPGA)-based approach by making high-quality instruments accessible in an integrated, software-upgradeable platform.

“Quantum computing pushes the performance limits of electronics, optics, and flexible real-time signal processing. We see software-defined instrumentation as the future of test and measurement systems for quantum computing,” said Andrew Horsley, CEO and Co-founder of Quantum Brilliance, a full-stack quantum computing company working on room temperature diamond technology.  “Moku:Pro is a workhorse of the lab and one of the most versatile photonics tools we’ve seen.”

Bringing Instrumentation Into the Modern Era
Moku:Pro brings test and measurement into the modern age, allowing engineers and researchers to dynamically switch between instruments rather than needing multiple stand-alone devices.  Advanced ADC blending technology ensures that each instrument can function with optimal sensitivity from RF to acoustic frequencies without compromising performance for flexibility. Full connectivity via Wi-Fi, Ethernet, and USB-C ensures industry-standard, hassle-free configuration.

A key benefit of software-defined instrumentation is that it gets better over time. Moku:Pro can receive over-the-air updates to deliver improved specifications, new instruments, or entirely new capabilities. Users can expect to see these benefits as soon as September when Liquid Instruments plans to release a feature that will give Moku:Pro the ability to run multiple instruments in conjunction with one another and hot-swap instruments in and out. In this multi-instrument mode, instruments can be combined and connected to form sophisticated signal-processing pipelines. Also slated for September release is a new cloud-based tool that will allow users to directly program Moku:Pro’s FPGA. With this capability, users can implement unique signal processing algorithms and create their own custom instruments, which will further widen the gap with conventional hardware.

Moku:Pro Specifications

  • 4 analog inputs and outputs
  • Blended ADC input (10-bit+18-bit) for low noise, high bandwidth applications
  • Sampling rate of 5 GSa/s (1 channel), 1.25 GSa/s (4 channels)
  • 9 integrated instruments, including a DC-600 MHz lock-in amplifier
  • 120 GB SSD for high-speed onboard storage
  • API support for Python and MATLAB
  • Starting at $12,000 for the base configuration, ranging up to $20,000 for the full suite.

A History of Success 
The Liquid Instruments technical leadership team brings deep expertise in complex measurements with experience from Australian National University, Max Planck Institute, Lockheed Martin, Caltech, and NASA’s Jet Propulsion Laboratory.  Moku:Pro expands the line of software-defined solutions from Moku:Lab, a twelve-instrument platform for research, and, more recently, Moku:Go, a complete and portable lab solution for undergraduate education.

For more information on Moku:Pro, visit: liquidinstruments.com

About Liquid Instruments
Liquid Instruments is a leader in precision software-defined instrumentation and is revolutionizing the way that students, engineers, and scientists learn, work, and discover. Their product line of hardware and software solutions leverages the computational power of modern FPGAs to create highly customizable instrumentation for controlling experiments and acquiring and analyzing data. The team’s IP in software-defined hardware enables Moku products to be dynamically reconfigurable in the field, serving a wide range of ever-changing experimental and process control situations. For more information, visit https://liquidinstruments.com.

The Project received funding from The Australian Government. Liquid Instruments gratefully acknowledges funding and support of the Australian Commonwealth Government through the CRC-P program administered by the Department of Industry Innovation and Science.

Media Contact
Codeword for Liquid Instruments
liquidinstruments@codewordagency.com
801-703-4092

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/37cb06a3-2242-4fe9-b6d2-0243a826051f

https://www.globenewswire.com/NewsRoom/AttachmentNg/8e84cd5f-7bf1-4276-9950-f57a12cfac19

Posted on

New architecture delivers nine instruments with real-time measurement capabilities to the research lab

Moku:Pro In Lab Setting

Moku:Pro brings test and measurement into the modern age, allowing engineers and researchers to dynamically switch between instruments rather than needing multiple stand-alone devices.

CANBERRA, Australia and SAN DIEGO, June 23, 2021 (GLOBE NEWSWIRE) — Liquid Instruments, an innovator in precision software-defined instrumentation, today announced Moku:Pro, a high-performance platform for engineering and research labs.

Moku:Pro accelerates the transition from traditional fixed-function test and measurement hardware to a flexible field-programmable gate array (FPGA)-based approach by making high-quality instruments accessible in an integrated, software-upgradeable platform.

“Researchers in engineering and physics face constantly evolving requirements – with changes occurring on timescales much shorter than the lifespan of test equipment,” said Daniel Shaddock, CEO of Liquid Instruments. “Moku:Pro’s software-enabled-hardware architecture allows it to evolve as your applications evolve, something that is simply not possible with conventional test equipment.”

Moku:Pro hosts nine powerful instruments, including an oscilloscope, lock-in amplifier, PID controller, phasemeter, arbitrary waveform generator, data logger, spectrum analyzer, frequency response analyzer, and waveform generator to ensure researchers have the instrumentation they need to quickly characterize their set up and scale their experiments. The platform was designed to meet the needs of researchers in a variety of fields, from aerospace to semiconductor. Moku:Pro’s instrument suite is particularly suited to photonics applications, including spectroscopy, microscopy, metrology, gravitational wave detection, active laser stabilization, and quantum computing.

Moku:Pro

Moku:Pro accelerates the transition from traditional fixed-function test and measurement hardware to a flexible field-programmable gate array (FPGA)-based approach by making high-quality instruments accessible in an integrated, software-upgradeable platform.

“Quantum computing pushes the performance limits of electronics, optics, and flexible real-time signal processing. We see software-defined instrumentation as the future of test and measurement systems for quantum computing,” said Andrew Horsley, CEO and Co-founder of Quantum Brilliance, a full-stack quantum computing company working on room temperature diamond technology.  “Moku:Pro is a workhorse of the lab and one of the most versatile photonics tools we’ve seen.”

Bringing Instrumentation Into the Modern Era
Moku:Pro brings test and measurement into the modern age, allowing engineers and researchers to dynamically switch between instruments rather than needing multiple stand-alone devices.  Advanced ADC blending technology ensures that each instrument can function with optimal sensitivity from RF to acoustic frequencies without compromising performance for flexibility. Full connectivity via Wi-Fi, Ethernet, and USB-C ensures industry-standard, hassle-free configuration.

A key benefit of software-defined instrumentation is that it gets better over time. Moku:Pro can receive over-the-air updates to deliver improved specifications, new instruments, or entirely new capabilities. Users can expect to see these benefits as soon as September when Liquid Instruments plans to release a feature that will give Moku:Pro the ability to run multiple instruments in conjunction with one another and hot-swap instruments in and out. In this multi-instrument mode, instruments can be combined and connected to form sophisticated signal-processing pipelines. Also slated for September release is a new cloud-based tool that will allow users to directly program Moku:Pro’s FPGA. With this capability, users can implement unique signal processing algorithms and create their own custom instruments, which will further widen the gap with conventional hardware.

Moku:Pro Specifications

  • 4 analog inputs and outputs
  • Blended ADC input (10-bit+18-bit) for low noise, high bandwidth applications
  • Sampling rate of 5 GSa/s (1 channel), 1.25 GSa/s (4 channels)
  • 9 integrated instruments, including a DC-600 MHz lock-in amplifier
  • 120 GB SSD for high-speed onboard storage
  • API support for Python and MATLAB
  • Starting at $12,000 for the base configuration, ranging up to $20,000 for the full suite.

A History of Success 
The Liquid Instruments technical leadership team brings deep expertise in complex measurements with experience from Australian National University, Max Planck Institute, Lockheed Martin, Caltech, and NASA’s Jet Propulsion Laboratory.  Moku:Pro expands the line of software-defined solutions from Moku:Lab, a twelve-instrument platform for research, and, more recently, Moku:Go, a complete and portable lab solution for undergraduate education.

For more information on Moku:Pro, visit: liquidinstruments.com

About Liquid Instruments
Liquid Instruments is a leader in precision software-defined instrumentation and is revolutionizing the way that students, engineers, and scientists learn, work, and discover. Their product line of hardware and software solutions leverages the computational power of modern FPGAs to create highly customizable instrumentation for controlling experiments and acquiring and analyzing data. The team’s IP in software-defined hardware enables Moku products to be dynamically reconfigurable in the field, serving a wide range of ever-changing experimental and process control situations. For more information, visit https://liquidinstruments.com.

The Project received funding from The Australian Government. Liquid Instruments gratefully acknowledges funding and support of the Australian Commonwealth Government through the CRC-P program administered by the Department of Industry Innovation and Science.

Media Contact
Codeword for Liquid Instruments
liquidinstruments@codewordagency.com
801-703-4092

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/37cb06a3-2242-4fe9-b6d2-0243a826051f

https://www.globenewswire.com/NewsRoom/AttachmentNg/8e84cd5f-7bf1-4276-9950-f57a12cfac19

Posted on

‫ڈومینیکا نے شہریت بذریعہ سرمایہ کاری فنڈز کا استعمال کرتے ہوئے نئے پرائمری اسکول کی تعمیر شروع کردی

لندن ، 22 جون ، 2021 / پی آر نیوز وائر / — حکومت ڈومینیکا نے مہاؤٹ پرائمری اسکول کی تعمیر کے آغاز کے موقع پر جزیرے میں حال ہی میں ایک تقریب کے انعقاد کے موقع پر تعلیم کے شعبے سے متعلق اپنے عزم کی تجدید کی ہے۔ تکمیل کے بعد ، اسکول  کی جانب سے مقامی بچوں کے لئے نئے مواقع  کے اعلان کی توقع کی جاتی ہےجبکہ اساتذہ اور انتظامیافراد کو ملازمتیں بھی فراہم کی جائیں گی۔ خاص طور پر ، اس منصوبے کو ڈومینیکا کی شہریت بذریہ  سرمایہ کاری (سی بی آئی) پروگرام کے ذریعے مالی تعاون فراہم کیا جائے گا۔ یہ جزیرے کے مختلف شعبوں میں قومی ترقیاتی اقدامات کو تعاون کی فراہمی کا ایک اہم ذریعہ ہے۔

پچھلے کچھ سالوں میں ، ڈومینیکا کے سی بی آئی پروگرام نے بیرون ملک طلبا کی تعلیم کی سرپرستی کرنے ، طلباء کے ساتھ ٹیوٹرز رکھنے اور 2017 میں سمندری طوفان ماریہ سے تباہ ہونے والے 15 اسکولوں کی بحالی کے لئے تقریبا 26 ملین ڈالر کی سرمایہ کاری کی ہے۔ پرائمری اسکول کی تقریب کے دوران وزیر اعظم روزویلٹ اسکیریٹ نے واضح کیا کہ ان کی حکومت جزیرے پر سیکنڈری تعلیم کو 100 فیصد قابل رسائی بنانے ، ڈومینیکا اسٹیٹ کالج کی تعمیر کرنے کی ذمہ دار ہے اور  اس بات کو یقینی بنا رہی ہے کہ یونیفارم اور نصابی کتب کے ساتھ ٹرانسپورٹ بھی باآسانیدستیاب ہو۔

وزیر برائے تعلیم ، آکٹویا الفریڈ نےکہا: “یہ حکومت طلباء ، اساتذہ اور انتظامیہ کے سکون کو یقینی بنانے کے لئے اپنے اسکول کے منصوبوں کی بہتری کے لئے بھاری سرمایہ کاری جاری رکھے گی۔ اساتذہ اور طلبہ کے لئے مناسب جگہ ، مناسب ہوا ، روشنی ، پانی ، بجلی اور انٹرنیٹ سروس جیسی تمام سہولیات سیکھنے کے ایک ماحول کی تشکیل میں معاون ہیں  جہاں طلبا ترقی کرسکیں۔ “

1993 میں بنایا گیا، ڈومینیکا کا سی بی آئی پروگرام ملک کی پائیدار ترقی کے لئے بہت اہمیت کا حامل رہا ہے۔ اس نے نہ صرف تعلیم میں اپنا کردار ادا کیا ہے ، بلکہ صحت سے متعلقاقدامات میں  بھی تعاون کیا ہے ، جن میں ایک جدید ترین اسپتال ، متعدد صحت مراکز ، سمندری طوفان سے محفوظ مکانات اور ماحول دوست ریزورٹس اور ولا زشامل ہیں۔ یہ امر جزیرے کے دنیا کی پہلی آب و ہوا سے مزاحمقوم بننے کے عزم کی تائید کرتاہے ، ایک ایسی کامیابی جس کا اعلان وزیر اعظم اسکیریٹ نے اقوام متحدہ میں 2017 میں کیا تھا۔

اپنے اور اپنے خاندان کے لئےایک محفوظ اور مستحکم منزل کے متلاشی سرمایہ کاروں کے لئے ، ڈومینیکا کا سی بی آئی پروگرام دوسری شہریت کے لئے ایک قابل اعتماد راستہ پیش کرتا ہے جسے سالانہ سی بی آئی انڈیکسجیسے  آزاد مطالعے نے بین الاقوامی سطح پر سراہا ہے۔ درخواست دہندگان کو جزیرے کا شہری بننے کے لئے ، اگر وہ ضروری حفاظتی چیک پاس کرلیتے  ہیں،صرف ملک کے اکنامک ڈائورسیفکیشن فنڈ میں معاشی شراکت کرنے یا پری-اَپرُووڈریئل اسٹیٹ خریدنے کی ضرورت ہے ۔

ایک بار شہری بننے کے بعد ، سرمایہ کار140 سے زائد مقامات ، متبادل کاروباری امکانات اور  ایک مستحکم جمہوریت میں دوسرے گھر تک اضافی سفری آزادی اور یونائیٹڈ اسٹیٹس اور یونائیٹڈ کنگڈم جیسے بڑے مراکز کے ساتھ تعلقات تک رسائی حاصل کرلیتے ہیں۔

رابطہ کیجئے:
447867942505+
pr@csglobalpartners.com
www.csglobalpartners.com

Posted on

Dominica Begins Construction on New Primary School Using Citizenship by Investment Funds

LONDON, June 22, 2021 /PRNewswire/ — The Government of Dominica is reaffirming its commitment to the education sector after a ceremony recently took place on the island to mark the beginning of the Mahaut Primary School construction. Once completed, the school is anticipated to herald new opportunities for local children while also providing jobs with teachers and administrators. Notably, the project will be funded by Dominica’s Citizenship by Investment (CBI) Programme – a vital tool in supporting national development initiatives across the island in various sectors.

Over the last few years, Dominica’s CBI Programme has invested roughly $26 million into sponsoring the education of students abroad, placing tutors with students and rehabilitating 15 schools that were devastated by Hurricane Maria in 2017. During the ceremony for the primary school, Prime Minister Roosevelt Skerrit highlighted that his government was responsible for making secondary education on the island 100 percent accessible, building the Dominica State College and ensuring that transportation along with uniforms and textbooks were also freely available.

Octavia Alfred, the Minister for Education, noted: “This government continues to invest heavily in the improvement of our school plans to ensure the comfort of students, teachers and administrators. Spaces for teachers and students with proper ventilation, lighting, water, electricity, and internet service all contribute to the creation of a learning environment where students can flourish.”

Established in 1993, Dominica’s CBI Programme has been crucial to the nation’s sustainable development. Not only has it contributed to education, but it has also backed healthcare initiatives, including the construction of a state-of-the-art hospital, multiple health centres, hurricane-resistant homes and environmentally friendly resorts and villas. It supports the island’s commitment to becoming the world’s first climate-resilient nation, a feat announced by Prime Minister Skerrit at the United Nations in 2017.

For savvy investors looking for a safe and stable destination for themselves and their families, Dominica’s CBI Programme offers a trusted route to second citizenship that has been internationally hailed by independent studies like the annual CBI Index. Applicants need only make an economic contribution to the country’s Economic Diversification Fund or purchase pre-approved real estate to become citizens of the island – if they pass the necessary security checks.

Once becoming citizens, investors gain access to increased travel freedom to over 140 destinations, alternative business prospects and a second home in a stable democracy with ties to major hubs like the United States and the United Kingdom.

Contact:
+447867942505
pr@csglobalpartners.com
www.csglobalpartners.com

 

Proudly powered by WordPress